Fresenius medical care showcases leadership and innovation in kidney care disease at 61st european renal association (era) congress 2024

Enhancing kidney care through innovative approaches by data-driven insights and real-world evidence company-wide experts highlight robust anonymized dialysis database convince study and the remarkable decrease of 23% in mortality rates for patients treated with high-volume hemodiafiltration will be presented bad homburg, germany , may 21, 2024 /prnewswire/ -- fresenius medical care (fme), the world's leading provider of products and services for individuals with renal diseases, today announced the presentation of nearly 40 company-affiliated research abstracts at the 61st european renal association (era) congress, taking place may 23-26, 2024, in stockholm, sweden and virtually. "our mission to improve the lives of people living with kidney disease requires working continually to enhance the standard of kidney disease care, and research plays an important role in that advancement," said dr. frank maddux, global chief medical officer and member of the management board for fresenius medical care.
FMS Ratings Summary
FMS Quant Ranking